Adynxx, Inc. Share Price Other OTC
Equities
ADYX
US00784D1037
Biotechnology & Medical Research
Sales 2017 | - | Sales 2018 | - | Capitalization | 5 400.26 |
---|---|---|---|---|---|
Net income 2017 | -11M -881M | Net income 2018 | -5M -400M | EV / Sales 2017 * | - |
Net cash position 2017 * | - 0 | Net cash position 2018 * | - 0 | EV / Sales 2018 * | - |
P/E ratio 2017 * |
-
| P/E ratio 2018 * |
-
| Employees | - |
Yield 2017 * |
-
| Yield 2018 * |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Julien Mamet
FOU | Founder | - | 30/09/07 |
Rick Orr
CEO | Chief Executive Officer | - | 30/11/10 |
Dina Gonzalez
DFI | Director of Finance/CFO | - | 31/12/09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eckard Weber
BRD | Director/Board Member | 73 | - |
Stanley Abel
BRD | Director/Board Member | - | 31/12/07 |
Dennis Podlesak
CHM | Chairman | 66 | - |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |